CA209-9DX: phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation

Annals of Oncology ◽

10.1093/annonc/mdy282.166 ◽

2018 ◽

Vol 29 ◽

pp. viii267-viii268 ◽

Cited By ~ 1

Author(s):

M.J. Jimenez Exposito ◽

M. Akce ◽

J.L. Montero Alvarez ◽

E. Assenat ◽

L.A. Balart ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

High Risk ◽

Curative Resection ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Risk Of Recurrence

Download Full-text

CA209-9DX: Phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation

Annals of Oncology ◽

10.1093/annonc/mdy432.059 ◽

2018 ◽

Vol 29 ◽

pp. ix65 ◽

Cited By ~ 2

Author(s):

M.J. Jimenez Exposito ◽

M. Akce ◽

J.L.M. Alvarez ◽

E. Assenat ◽

L.A. Balart ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

High Risk ◽

Curative Resection ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Risk Of Recurrence

Download Full-text

Abstract No. 526 CheckMate-9DX: phase 3, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2018.12.607 ◽

2019 ◽

Vol 30 (3) ◽

pp. S227-S228

Author(s):

M. Jimenez Exposito ◽

M. Akce ◽

J. Alvarez ◽

E. Assenat ◽

L. Balart ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

High Risk ◽

Curative Resection ◽

Blind Study ◽

Double Blind Study ◽

Phase 3 ◽

Double Blind ◽

Risk Of Recurrence

Download Full-text

254TiP ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.10.248 ◽

2020 ◽

Vol 31 ◽

pp. S1341-S1342

Author(s):

D. Lorusso ◽

Y. Xiang ◽

N. Colombo ◽

R. Coleman ◽

L. Randall ◽

...

Keyword(s):

Cervical Cancer ◽

High Risk ◽

Locally Advanced ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Advanced Cervical Cancer ◽

Double Blind ◽

Locally Advanced Cervical Cancer

Download Full-text

A phase III, randomised, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation in patients with high-risk cutaneous squamous cell carcinoma (CSCC)

Annals of Oncology ◽

10.1093/annonc/mdz255.060 ◽

2019 ◽

Vol 30 ◽

pp. v560

Author(s):

D. Rischin ◽

M.G. Fury ◽

I. Lowy ◽

E. Stankevich ◽

S. Li ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

High Risk ◽

Cell Carcinoma ◽

Squamous Cell ◽

Cutaneous Squamous Cell Carcinoma ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Post Surgery

Download Full-text

Phase III Clinical Trial Comparing Iopamidol 250 mgI/mL and Iopamidol 300mgI/mL in Cerebral Angiography: Multicenteric, Randomized and Double Blind Study

Journal of the Korean Radiological Society ◽

10.3348/jkrs.2007.57.6.501 ◽

2007 ◽

Vol 57 (6) ◽

pp. 501

Author(s):

Hyobin Seo ◽

Moon Hee Han ◽

Bae Ju Kwon ◽

So Hyang Im ◽

Cheolkyu Jung ◽

...

Keyword(s):

Clinical Trial ◽

Cerebral Angiography ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Phase Iii Clinical Trial

Download Full-text

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkq254 ◽

2010 ◽

Vol 65 (Supplement 4) ◽

pp. iv41-iv51 ◽

Cited By ~ 64

Author(s):

G. R. Corey ◽

M. H. Wilcox ◽

G. H. Talbot ◽

D. Thye ◽

D. Friedland ◽

...

Keyword(s):

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Ceftaroline Fosamil ◽

Skin Structure ◽

Complicated Skin

Download Full-text

Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study

International Journal of Reproductive BioMedicine ◽

10.29252/ijrm.14.5.309 ◽

2016 ◽

Vol 14 (5) ◽

pp. 309-316 ◽

Cited By ~ 11

Author(s):

Azam Azargoon ◽

Raheb Ghorbani ◽

Fereshteh Aslebahar ◽

◽

...

Keyword(s):

Preterm Birth ◽

High Risk ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Neonatal Complications ◽

High Risk Women ◽

Vaginal Progesterone

Download Full-text

Survival advantage of exemestane (EXE, Aromasin®) over megestrol acetate (MA) in postmenopausal women with advanced breast cancer (ABC) refractory to tamoxifen (TAM): results of a phase III randomized double-blind study

European Journal of Cancer ◽

10.1016/s0959-8049(99)80705-9 ◽

1999 ◽

Vol 35 ◽

pp. S84 ◽

Cited By ~ 2

Author(s):

E. Bajetta ◽

L.Y. Dirix ◽

L.E. Fein ◽

S.E. Jones ◽

J. Cervek ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Survival Advantage ◽

Advanced Breast ◽

Blind Study ◽

Megestrol Acetate ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind

Download Full-text

Patient-reported outcomes (PROs) from TITAN: A phase III, randomized, double-blind study of apalutamide (APA) versus placebo (PBO) added to androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC)

Annals of Oncology ◽

10.1093/annonc/mdz248.008 ◽

2019 ◽

Vol 30 ◽

pp. v330-v331

Author(s):

N. Agarwal ◽

K. McQuarrie ◽

A. Bjartell ◽

S. Chowdhury ◽

A J P D S Gomes ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Patient Reported Outcomes ◽

Androgen Deprivation ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Patient Reported

Download Full-text

Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis

Clinical Therapeutics ◽

10.1016/s0149-2918(00)83041-6 ◽

2000 ◽

Vol 22 (12) ◽

pp. 1421-1432 ◽

Cited By ~ 20

Author(s):

John J Murray ◽

Eric Solomon ◽

Dennis McCluskey ◽

Jie Zhang ◽

Robert Palmer ◽

...

Keyword(s):

Extended Release ◽

Maxillary Sinusitis ◽

Immediate Release ◽

Adult Patients ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind

Download Full-text